Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
Condition(s):CataractLast Updated:July 8, 2009Completed
Hide Studies Not Open or Pending
Condition(s):CataractLast Updated:July 8, 2009Completed
Condition(s):OsteoarthritisLast Updated:February 18, 2020Terminated
Condition(s):PainLast Updated:January 5, 2016Completed
Condition(s):Acute Pseudophakic Cystoid Macular EdemaLast Updated:March 19, 2009Completed
Condition(s):Pain Control With IUD InsertionLast Updated:December 23, 2015Completed
Condition(s):Proliferative Diabetic Retinopathy; Macular EdemaLast Updated:March 20, 2015Completed
Condition(s):Pain; Dental ImpactionLast Updated:February 9, 2017Completed
Condition(s):Cystoid Macular Edema; CataractLast Updated:March 12, 2014Completed
Condition(s):Healthy SubjectsLast Updated:February 8, 2017Completed
Condition(s):Subacromial Impingement; Subacromial Impingement SyndromeLast Updated:March 7, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.